Impax broke U.S. antitrust law by delaying generic drug, jury told
BOSTON (Reuters) - Impax Laboratories Inc went to trial on Monday over allegations by major retailers and consumers that the company agreed to delay launching a generic version of acne medication Solodyn in exchange for millions of dollars from the manufacturer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news